The CSF t-tau levels were 270.6  ± 145.3 pg/ml (mean ± SD) and the CSF p-tau levels were 41.3 ± 13.3 pg/ml in patients with PML. The gene discussed is MAPT; the disease is progressive multifocal leukoencephalopathy.